Abstract
The article reviews research conducted with the Australian Remote Memory Test (ARMB) since its development first reported in 2001. Data from case studies and experimental investigations that have used the ARMB are summarised, and the use made of these data in reviews of the literature is noted. The ARMB has been found sensitive to disease processes such as herpes simplex, stroke, and epilepsy and lesion effects such as temporal lobectomy. The pattern of findings is consistent with current understanding of memory function. The studies have, however, pointed to factors that need to be considered in using the test, including patient medication and education level. Directions for future research with the test are briefly noted.
Key words: